Qube Research & Technologies (QRT)
KNTE

Qube Research & Technologies (QRT)’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio KNTE Stock Details KNTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,262
Closed -$16.7K – 4964
2024
Q1 		$16.7K Buy
6,262
+5,949
+1,901% +$14.7K ﹤0.01% 3732
2023
Q4 		$742 Sell
313
-4,308
-93% -$7.63K ﹤0.01% 3891
2023
Q3 		$6.47K Sell
4,621
-49,205
-91% -$118K ﹤0.01% 3401
2023
Q2 		$163K Buy
+53,826
New +$208K ﹤0.01% 1831
2021
Q1 		– Sell
-6,072
Closed -$242K – 2523
2020
Q4 		$242K Buy
+6,072
New +$244K ﹤0.01% 1451

Qube Research & Technologies (QRT)'s KNTE Position: Q2 2024 in Review

Qube Research & Technologies (QRT) sold out of Kinnate Biopharma Inc. Common Stock (KNTE) in Q2 2024, closing a stake of 6,262 shares — an estimated $16.7K sold.

Qube Research & Technologies (QRT) first reported a position in KNTE in Q4 2020 and held it in 5 quarters. The position peaked at $242K in Q4 2020. 0 funds tracked by Wall St. Rank hold KNTE as of Q2 2024.

  • Qube Research & Technologies (QRT) reported no remaining Kinnate Biopharma Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 6,262 Kinnate Biopharma Inc. Common Stock shares in Q2 2024, an estimated $16.7K.
  • Qube Research & Technologies (QRT) first reported a position in Kinnate Biopharma Inc. Common Stock in Q4 2020 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s Kinnate Biopharma Inc. Common Stock position peaked at $242K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Kinnate Biopharma Inc. Common Stock as of Q2 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.